查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402596

止血剂和组织密封剂市场：按产品类型、按应用、按最终用户、按地区

Hemostasis and Tissue Sealing Agents Market, By Product Type, By Application, By End User, and By Region
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球止血剂和组织封闭剂市场规模为33.9亿美元，2023年至2030年复合年增长率为5.6%，预计到2030年将达到49.5亿美元。

报告范围 报告详情
基准年 2022年 2023年市场规模 33.9亿美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 5.60% 2030年市场规模预测 49.5亿美元
图 1. 止血剂和组织封闭剂的全球市场占有率(%)（按地区），2023 年
止血与组织封闭剂市场-IMG1

止血剂和组织密封剂在手术中发挥重要作用，使外科医生能够控制出血并密封组织。这些药物的作用是在切口或伤口上形成保护层并促进身体的自然凝血过程。常用的止血和组织封闭产品包括封闭剂、黏剂、纤维蛋白贴片、胶原蛋白溶液和可吸收凝胶。由于心血管外科、骨科、整形外科血管外科和普通外科等各个外科领域对更有效的出血控制解决方案的需求不断增加，全球止血和组织封闭剂市场正在成长。

市场动态：

推动止血剂和组织封闭剂市场的关键驱动因素包括全球外科手术的快速增加、对微创手术的偏好不断增加、新兴国家医疗保健支出的增加以及产品系列的改善。技术进步导致了这一点。然而，由于安全问题而导致的产品召回、严格的监管标准以及大型非专利製造商的价格压力等因素构成了重大挑战。从积极的一面来看，我们正在努力开发具有卓越功效的下一代止血材料和密封剂，为市场相关人员开闢新的途径。组织黏合剂在创伤修復中的使用不断增加也为止血和组织密封剂市场的成长提供了诱人的机会。

本研究的主要特点

  • 该研究报告对全球止血剂和组织封闭剂市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和復合年增长率。
  • 它揭示了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据以下参数（例如公司亮点、产品系列、主要亮点、绩效和策略）介绍了全球止血剂和组织密封剂市场的主要企业。
  • 本研究涵盖的主要企业包括 Ethicon（强生子公司）、Baxter International、CryoLife、B. Braun Melsungen AG、Covidien（现为 Medtronic 的一部分）、Integra LifeSciences、辉瑞、BD、Teleflex 和 Arch Therapeutics。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球止血剂和组织密封剂市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球止血剂和组织密封剂市场的各种策略矩阵来促进他们的决策。

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章止血剂和组织封闭剂市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章止血剂和组织封闭剂市场，依产品类型，2018-2030

  • 局部止血剂和黏剂
  • 组织密封剂

第六章止血剂与组织封闭剂市场，依应用划分，2018-2030

  • 心血管外科
  • 整形外科
  • 一般外科
  • 神经外科
  • 其他的

第 7 章止血剂和组织封闭剂市场，按最终用户划分，2018-2030 年

  • 医院
  • 门诊手术中心
  • 居家照护环境

第八章止血剂和组织封闭剂市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争形势

  • Ethicon（a subsidiary of Johnson & Johnson）
  • Baxter International
  • CryoLife
  • B.Braun Melsungen AG
  • Covidien（now part of Medtronic）
  • Integra LifeSciences
  • Pfizer Inc.
  • BD
  • Teleflex
  • Arch Therapeutics

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1567

The global hemostasis and tissue sealing agents market size is valued at US$ 3.39 Billion in 2023 and is expected to reach US$ 4.95 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.39 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 4.95 Bn
Figure 1. Global Hemostasis And Tissue Sealing Agents Market Share (%), By Region, 2023
Hemostasis and Tissue Sealing Agents Market - IMG1

Hemostasis and tissue sealing agents play a vital role in surgical procedures by enabling surgeons to control bleeding and seal tissues. They work by forming a protective layer over incisions and wounds to accelerate the body's natural clotting process. Some commonly used hemostasis and tissue sealing products include sealants, glues, fibrin patches, collagen-based solutions, and absorbable gels. The global hemostasis and tissue sealing agents market has been growing in response to the rising need for more effective hemorrhage management solutions across various surgical specialties like cardiovascular, orthopedic, neurovascular, and general surgeries.

Market Dynamics:

The key drivers fueling the hemostasis and tissue sealing agents market include rapid growth in surgical procedures globally, increasing preference for minimally invasive surgeries, rising healthcare spending in emerging nations, and technological advancements leading to improved product portfolios. However, factors such as product recalls owing to safety concerns, stringent regulatory norms, and price pressures from large generic manufacturers pose significant challenges. On the positive side, ongoing research and development towards developing next-gen hemostats and sealants with superior efficacy is opening new avenues for market players. Growing applications of tissue adhesives in traumatic injury repair also present attractive opportunities for growth of hemostasis and tissue sealing agents market.

Key Features of the Study:

  • This report provides an in-depth analysis of the global hemostasis and tissue sealing agents market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hemostasis and tissue sealing agents market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Ethicon (a subsidiary of Johnson & Johnson), Baxter International, CryoLife, B. Braun Melsungen AG, Covidien (now part of Medtronic), Integra LifeSciences, Pfizer, BD, Teleflex and Arch Therapeutics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global hemostasis and tissue sealing agents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hemostasis and tissue sealing agents market

Detailed Segmentation:

  • By Product Type:
    • Topical Hemostats & Adhesives
    • Tissue Sealing Agents
  • By Application:
    • Cardiovascular Surgery
    • Orthopedic Surgery
    • General Surgery
    • Neurosurgery
    • Others
  • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Home Care Settings
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Ethicon (a subsidiary of Johnson & Johnson)
    • Baxter International
    • CryoLife
    • Braun Melsungen AG
    • Covidien (now part of Medtronic)
    • Integra LifeSciences
    • Pfizer
    • BD
    • Teleflex
    • Arch Therapeutics

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Hemostasis and Tissue Sealing Agents Market , By Product Type
    • Global Hemostasis and Tissue Sealing Agents Market , By Application
    • Global Hemostasis and Tissue Sealing Agents Market , By End User
    • Global Hemostasis and Tissue Sealing Agents Market , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Hemostasis and Tissue Sealing Agents Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Hemostasis and Tissue Sealing Agents Market, By Product Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Topical Hemostats & Adhesives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Tissue Sealing Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Hemostasis and Tissue Sealing Agents Market, By Application, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Cardiovascular Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Orthopedic Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • General Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Neurosurgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Hemostasis and Tissue Sealing Agents Market, By End User, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Hemostasis and Tissue Sealing Agents Market, By Region, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Ethicon (a subsidiary of Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Baxter International
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CryoLife
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • B.Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Covidien (now part of Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integra LifeSciences
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teleflex
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Arch Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • Research Methodology
  • About us